Categories: News

Angels belonging to Otani, former stealing king’s beer infielder acquired

The Angels, to which Shohei Ohtani, a pitcher of the US Major League Baseball (MLB), belongs, won the former National League stealing king Jonathan Villar infielder (31) on the 2nd. The MLB official website reported.

Beer has played 46 games in the Cubs this season, with a batting average of 20%, 2 minutes, 2 home runs, 15 RBIs, and 6 stolen bases. He received a de facto out-of-force notification on June 24 and had a free contract on June 28.

Last season, he played 142 games in Mets with a batting average of 20%, 4 minutes, 9 home runs, 18 home runs, 42 RBIs, and 14 stolen bases. He marked 62 stolen bases in 2016 when he belonged to Brewers and became the National League stolen base king.

Coach Phil Nevin has indicated that he will be appointed to third base as the back-up for Anthony Rendon infielder, who was desperate this season due to a breakdown.

As a result, the Angels demoted Matt Thais infielder to a minor under the umbrella.

Jimmy Fraley

Recent Posts

GRUPO ELEKTRA ANNOUNCES REVENUE OF Ps.40,045 MILLION AND EBITDA OF Ps.4,119 MILLION IN THE THIRD QUARTER OF 2022

Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services…

2 years ago

mCloud Announces Proposed Unsecured Loan from Strategic Investors

mCloud Technologies Corp. (Nasdaq: MCLD) (TSX-V: MCLD), ("mCloud" or the "Company") a leading provider of AI-powered asset…

2 years ago

TransPerfect Acquires Sterling Technology

TransPerfect, the world's largest provider of language and technology solutions for global business, announced that…

2 years ago

Comerica Incorporated Names Kelly Gage, Director of Investor Relations; Darlene Persons to Retire on April 1

Comerica Incorporated (NYSE: CMA) announced that Kelly Gage, National Director of Sales and Strategy for the Commercial Bank…

2 years ago

Genomadix Inc. Announces Know-How License Agreement with Mayo Clinic

Genomadix announced it has entered into a know-how license agreement and stock purchase agreement with…

2 years ago

ASLAN Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the…

2 years ago

This website uses cookies.